A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance

NCT05102370 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Clonal Cytopenia of Undetermined Significance
CCUS Clonal Cytopenia of Undetermined Significance

Interventions

DRUG: Enasidenib

Sponsor

Memorial Sloan Kettering Cancer Center